BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10664524)

  • 1. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
    Broglio F; Benso A; Gottero C; Vito LD; Aimaretti G; Fubini A; Arvat E; Bobbio M; Ghigo E
    Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
    Broglio F; Fubini A; Morello M; Arvat E; Aimaretti G; Gianotti L; Boghen MF; Deghenghi R; Mangiardi L; Ghigo E
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):417-30. PubMed ID: 10468900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
    Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
    Valetto MR; Bellone J; Baffoni C; Savio P; Aimaretti G; Gianotti L; Arvat E; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.
    Bellone J; Aimaretti G; Bellone S; Baffoni C; Corneli G; Origlia C; Cappa M; Ghigo E
    J Endocrinol Invest; 2000 Feb; 23(2):97-101. PubMed ID: 10800762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
    Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
    Beccaria L; Marziani E; Manzoni P; Arvat E; Valetto MR; Gianotti L; Ghigo E; Chiumello G
    Dement Geriatr Cogn Disord; 1998; 9(2):78-81. PubMed ID: 9524798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction.
    Aimaretti G; Bellone S; Bellone J; Chiabotto P; Baffoni C; Corneli G; Origlia C; de Sanctis C; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):287-93. PubMed ID: 10718826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood.
    Bellone J; Aimaretti G; Valetto MR; Bellone S; Baffoni C; Arvat E; Seminara S; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Oct; 135(4):421-4. PubMed ID: 8921823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
    Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients.
    Grottoli S; Razzore P; Arvat E; Oleandri SE; Rossetto R; Ciccarelli E; Camanni F; Ghigo E
    J Endocrinol Invest; 1997 Nov; 20(10):597-602. PubMed ID: 9438917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short children with familial short stature show enhancement of somatotroph secretion but normal IGF-I levels.
    Bellone S; Corneli G; Bellone J; Baffoni C; Rovere S; de Sanctis C; Bona G; Ghigo E; Aimaretti G
    J Endocrinol Invest; 2002 May; 25(5):426-30. PubMed ID: 12035938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine potentiates both basal and GHRH-induced GH secretion in children.
    Bellone J; Farello G; Bartolotta E; Aimaretti G; Bellone S; Mucci M; De Matteis F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):61-4. PubMed ID: 9302373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity.
    Ghigo E; Procopio M; Boffano GM; Arvat E; Valente F; Maccario M; Mazza E; Camanni F
    Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.